Christopher Morabito - 10 May 2021 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Medical Officer
Signature
/s/ Peter Thomson, as attorney-in-fact for Christopher Morabito
Issuer symbol
FULC
Transactions as of
10 May 2021
Net transactions value
$0
Form type
4
Filing time
12 May 2021, 16:30:29 UTC
Next filing
29 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +163,000 $0.000000 163,000 10 May 2021 Common Stock 163,000 $10.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 10, 2021 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of May 10, 2021. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.